Circulating Irisin in Relation to Insulin Resistance and the Metabolic Syndrome

Abstract

Irisin is associated with increased risk of MetS, cardiometabolic variables, and CVD in humans, indicating either increased secretion by adipose/muscle tissue and/or a compensatory increase of irisin to overcome an underlying irisin resistance in these subjects.